AMERICAN INTERNATIONAL HOLDINGS CORP.AMIH

時価総額
$9.8万
PER
エネルギー(石油・ガス探査・サービス)の新興企業。水素発生装置や燃料電池、油田開発サービスを展開。2023年2月15日の株式交換でCycle Energyを取り込み、2022年6月30日にEPIQ MDを30万ドルで売却。米国テキサス州を中心に展開。
2011年
12月31日
2015年
12月31日
2016年
12月31日
2017年
12月31日
2018年
12月31日
2019年
12月31日
2020年
12月31日
2021年
12月31日
2022年
12月31日
Net loss from continuing operations-------6,136,105-10,225,497-2,863,918
Net income (loss) from discontinued operations-------1,203,785244,586-14,199
Amortization of debt discount-----76,230777,96423
Change in derivative liabilities--------2
Depreciation408,635-----55,280-12,698
Derivatives expenses-------4460,960
Forgiveness of loan-------45,500-
Imputed interest expense---1,799---1,979-
Interest expense147,525--1,7992,97669,916---
Gain(Loss) on disposal--------323,262
(Gain) loss on loans settlement-------1,041,445--
Stock issued for services rendered-----234452,624
Stock issued for in process research and development-------601,852-
Inventory-581,622-----1,327-3,8533,8408,998
Prepaid expenses-----346,654-362,187-3,33313,368
Rent deposits-------26,8933,5994,492
Accounts payable and accrued liabilities-316,473-------27,721
Accrued interest payable----85242,564212,69077,296324,025
Accrued compensation - related parties-----58,48896,000-5,5006,500
Deferred revenue - related parties--------11,745
NET CASH USED IN OPERATING ACTIVITIES OF CONTINUING OPERATIONS701,356-------1,888,506-1,644,747
NET CASH USED IN OPERATING ACTIVITIES OF DISCONTINUED OPERATIONS--------323,256-93,003
NET CASH USED IN OPERATING ACTIVITIES--102,248-16,944-14,546-56,090900,435-2,155,944-2,211,762-1,737,750
Capital expenditures for property and equipment397,557----33,55427,392-69,457
Net cash inflow from disposition of Mangoceuticals, Inc.--------85,753
Net cash inflow from disposition of EPIQ MD, Inc.--------298,377
NET CASH PROVIDED IN INVESTING ACTIVITIES OF CONTINUING OPERATIONS--------314,673
NET CASH PROVIDED BY USED IN INVESTING ACTIVITIES OF DISCONTINUED OPERATIONS-------10,000-
NET CASH USED IN INVESTING ACTIVITIES OF DISCONTINUED OPERATIONS-106,766-----103,554-27,39210,000314,673
Proceeds from borrowings - related parties--17,26914,227100,500165,57111,919141,928-
Repayment of borrowings - related parties----86,928121,03840,000141,9282,000
Proceeds from borrowings--------417,758
(Repayment) of borrowings------15,421427,500-
(Repayment) of note payable--------5,483
Proceeds from sales of stock----43,00035,00046,500100,000-
NET CASH PROVIDED BY FINANCING ACTIVITIES OF CONTINUING OPERATIONS-------3410,275
NET CASH USED IN FINANCING ACTIVITIES OF DISCONTINUED OPERATIONS--------25,164-50
NET CASH PROVIDED BY FINANCING ACTIVITIES-608,607102,34317,26914,22756,572443,033947,1803410,225
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS-----1-1,236,1361-1,012,852
Cash paid for interest137,251----27,3522,674106,677-
Common shares issued for notes conversion-------11
Common shares issued for loan settlement-----105,00086,771111,466-
Discounts on convertible notes--------3,756,000-
Initial debt discount--------400,799
Adoption of ASC 842--------69,439
Settlement of derivative liabilities-------1474,735
Gain on disposition of Mangoceuticals, Inc.--------102,092